Large-cap Health Care company Smith & Nephew has logged a -12.2% change today on a trading volume of 747,883. The average volume for the stock is 655,507.
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. Based in Watford, United Kingdom the company has 18,000 full time employees and a market cap of $11,039,191,040. Smith & Nephew currently offers its equity investors a dividend that yields 1.3% per year.
The company is now trading -30.0% away from its average analyst target price of $36.17 per share. The 3 analysts following the stock have set target prices ranging from $32.0 to $39.0, and on average give Smith & Nephew a rating of buy.
Over the last 52 weeks, SNN stock has risen 22.0%, which amounts to a -12.6% difference compared to the S&P 500. The stock's 52 week high is $31.72 whereas its 52 week low is $23.24 per share. With its net margins declining an average -16.5% over the last 6 years, Smith & Nephew may not have a strong enough profitability trend to support its stock price.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2023 | 5,549,000 | 263,000 | 5 | 25.0 |
| 2022 | 5,215,000 | 223,000 | 4 | -60.0 |
| 2021 | 5,212,000 | 524,000 | 10 | 0.0 |
| 2020 | 4,560,000 | 448,000 | 10 | -16.67 |
| 2019 | 5,138,000 | 600,000 | 12 | -14.29 |
| 2018 | 4,904,000 | 663,000 | 14 |
